BIENAIME JEAN JACQUES

CIK 000122159011 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001221590

Recent Transactions

50 trades

Purchase
Keros Therapeutics, Inc.$KROS
Common Stock
2026-06-15$10.19/sh+1,000→ 17,592 total
Award
Immunome Inc.$IMNM
Director Stock Option (right to buy)
2026-06-10+9,897→ 9,897 total
Award
INCYTE CORP$INCY
Common Stock
2026-06-08+1,642→ 24,424 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2026-06-08+6,111→ 6,111 total
Sale
Immunome Inc.$IMNM
Common Stock
2026-06-05$19.44/sh−500→ 42,915 total
Sale
Immunome Inc.$IMNM
Common Stock
2026-06-05$19.41/sh−10,000→ 32,915 total
Purchase
Immunome Inc.$IMNM
Common Stock
2026-06-05$19.48/sh+6,000→ 38,915 total
Purchase
Immunome Inc.$IMNM
Common Stock
2026-06-05$19.46/sh+3,500→ 42,415 total
Purchase
Immunome Inc.$IMNM
Common Stock
2026-06-05$19.27/sh+1,000→ 43,415 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2026-06-03+7,142→ 16,592 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2026-06-03+7,433→ 7,433 total
Purchase
Ascendis Pharma A/S$ASND
Ordinary Shares
2026-05-29$223.76/sh+200→ 600 total
Purchase
Ascendis Pharma A/S$ASND
Ordinary Shares
2026-05-29$222.30/sh+200→ 800 total
Purchase
Ascendis Pharma A/S$ASND
Ordinary Shares
2026-05-29$223.50/sh+100→ 900 total
Exercise/Conversion
INCYTE CORP$INCY
Common Stock
2026-05-26$84.53/sh+15,000→ 35,841 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2026-05-26$97.10/sh−13,059→ 22,782 total
Exercise/Conversion
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2026-05-26−15,000→ 0 total
Purchase
Ascendis Pharma A/S$ASND
Ordinary Shares
2026-05-26$236.24/sh+200→ 200 total
Purchase
Ascendis Pharma A/S$ASND
Ordinary Shares
2026-05-26$239.37/sh+200→ 400 total
Purchase
Keros Therapeutics, Inc.$KROS
Common Stock
2026-05-15$10.58/sh+1,000→ 9,450 total
Purchase
Immunome Inc.$IMNM
Common Stock
2026-05-15$20.70/sh+5,000→ 43,415 total
Purchase
Keros Therapeutics, Inc.$KROS
Common Stock
2026-04-15$11.70/sh+1,000→ 8,450 total
Purchase
Immunome Inc.$IMNM
Common Stock
2026-03-11$21.55/sh+1,000→ 38,415 total
Purchase
Immunome Inc.$IMNM
Common Stock
2026-03-10$22.12/sh+1,000→ 37,415 total
Purchase
Keros Therapeutics, Inc.$KROS
Common Stock
2026-03-09$11.21/sh+2,000→ 7,450 total
Award
Immunome Inc.$IMNM
Director Stock Option (right to buy)
2025-06-10+18,864→ 18,864 total
Award
INCYTE CORP$INCY
Common Stock
2025-06-10+2,518→ 20,841 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2025-06-10+9,216→ 9,216 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-06-04+5,250→ 5,450 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 total
Purchase
Immunome Inc.$IMNM
Common Stock
2025-06-03$9.38/sh+5,000→ 36,415 total
Purchase
Immunome Inc.$IMNM
Common Stock
2025-03-25$7.78/sh+7,800→ 31,415 total
Purchase
Immunome Inc.$IMNM
Common Stock
2025-03-24$8.21/sh+7,000→ 23,615 total
Purchase
Immunome Inc.$IMNM
Common Stock
2024-08-16$13.94/sh+7,000→ 16,615 total
Award
Immunome Inc.$IMNM
Stock option (right to buy)
2024-06-13+11,333→ 11,333 total
Award
INCYTE CORP$INCY
Common Stock
2024-06-12+2,830→ 18,323 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2024-06-12+12,517→ 12,517 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-06-03+17,600→ 17,600 total
Purchase
Immunome Inc.$IMNM
Common Stock
2024-05-21$13.57/sh+2,000→ 9,615 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-20$77.05/sh−1,202→ 473,792 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-05-10−20,000→ 51,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-10$63.10/sh+20,000→ 494,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-10$81.14/sh−20,000→ 474,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-09$63.10/sh+20,000→ 494,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-09$81.62/sh−20,000→ 474,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-05-09−20,000→ 71,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-12$63.10/sh+20,000→ 494,994 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2024-04-12−20,000→ 91,000 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-12$91.26/sh−20,000→ 474,994 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-04-11$90.99/sh−20,000→ 474,994 total

BIENAIME JEAN JACQUES

Recent Transactions

Companies

Recent Filings

Address